CA2637851C - Method of routing electrical current to bodily tissues via implanted passive conductors - Google Patents
Method of routing electrical current to bodily tissues via implanted passive conductors Download PDFInfo
- Publication number
- CA2637851C CA2637851C CA2637851A CA2637851A CA2637851C CA 2637851 C CA2637851 C CA 2637851C CA 2637851 A CA2637851 A CA 2637851A CA 2637851 A CA2637851 A CA 2637851A CA 2637851 C CA2637851 C CA 2637851C
- Authority
- CA
- Canada
- Prior art keywords
- electrical current
- electrode
- electrical
- body tissue
- target body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004020 conductor Substances 0.000 title claims abstract description 122
- 238000000034 method Methods 0.000 title abstract description 21
- 210000001519 tissue Anatomy 0.000 claims abstract description 181
- 239000007943 implant Substances 0.000 claims abstract description 61
- 230000004936 stimulating effect Effects 0.000 claims abstract description 59
- 230000001537 neural effect Effects 0.000 claims abstract description 44
- 206010033675 panniculitis Diseases 0.000 claims abstract description 24
- 210000004304 subcutaneous tissue Anatomy 0.000 claims abstract description 24
- 210000005036 nerve Anatomy 0.000 claims description 110
- 230000000903 blocking effect Effects 0.000 claims description 59
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 37
- 208000035475 disorder Diseases 0.000 claims description 37
- 208000002193 Pain Diseases 0.000 claims description 16
- 230000002051 biphasic effect Effects 0.000 claims description 11
- 230000000541 pulsatile effect Effects 0.000 claims description 11
- 208000008238 Muscle Spasticity Diseases 0.000 claims description 9
- 229920001971 elastomer Polymers 0.000 claims description 9
- 208000018198 spasticity Diseases 0.000 claims description 9
- 206010044565 Tremor Diseases 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 210000003169 central nervous system Anatomy 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 230000002093 peripheral effect Effects 0.000 claims description 5
- 210000001428 peripheral nervous system Anatomy 0.000 claims description 5
- 208000018737 Parkinson disease Diseases 0.000 claims description 4
- 230000002567 autonomic effect Effects 0.000 claims description 4
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 3
- 208000014094 Dystonic disease Diseases 0.000 claims description 3
- 208000010428 Muscle Weakness Diseases 0.000 claims description 3
- 206010028372 Muscular weakness Diseases 0.000 claims description 3
- 206010046555 Urinary retention Diseases 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 239000004917 carbon fiber Substances 0.000 claims description 3
- 229920001940 conductive polymer Polymers 0.000 claims description 3
- 208000010118 dystonia Diseases 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000012266 salt solution Substances 0.000 claims description 3
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 239000002003 electrode paste Substances 0.000 claims description 2
- 125000004122 cyclic group Chemical class 0.000 claims 2
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 230000037361 pathway Effects 0.000 abstract description 12
- 230000000638 stimulation Effects 0.000 description 88
- 210000003205 muscle Anatomy 0.000 description 27
- 210000003932 urinary bladder Anatomy 0.000 description 27
- 238000007915 intraurethral administration Methods 0.000 description 22
- 210000001617 median nerve Anatomy 0.000 description 20
- 210000005070 sphincter Anatomy 0.000 description 19
- 230000008602 contraction Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 230000036982 action potential Effects 0.000 description 13
- 210000004556 brain Anatomy 0.000 description 12
- 230000004913 activation Effects 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 210000003050 axon Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 210000002979 radial nerve Anatomy 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- 208000016285 Movement disease Diseases 0.000 description 6
- 210000003708 urethra Anatomy 0.000 description 6
- 210000004227 basal ganglia Anatomy 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 210000000578 peripheral nerve Anatomy 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 210000003901 trigeminal nerve Anatomy 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 206010020852 Hypertonia Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 210000003477 cochlea Anatomy 0.000 description 3
- 210000001787 dendrite Anatomy 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 3
- 210000004705 lumbosacral region Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000001328 optic nerve Anatomy 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000000278 spinal cord Anatomy 0.000 description 3
- 210000001032 spinal nerve Anatomy 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- 229910000575 Ir alloy Inorganic materials 0.000 description 2
- 208000021642 Muscular disease Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 206010008129 cerebral palsy Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000003019 respiratory muscle Anatomy 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000020431 spinal cord injury Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 206010044652 trigeminal neuralgia Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 241000270728 Alligator Species 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000003078 Generalized Epilepsy Diseases 0.000 description 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 208000019430 Motor disease Diseases 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000037158 Partial Epilepsies Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
- 229960005054 acepromazine Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 229960001736 buprenorphine Drugs 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- PRQRQKBNBXPISG-UHFFFAOYSA-N chromium cobalt molybdenum nickel Chemical compound [Cr].[Co].[Ni].[Mo] PRQRQKBNBXPISG-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 210000005071 external anal sphincter Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940015042 glycopyrrolate Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004007 neuromodulation Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 210000003523 substantia nigra Anatomy 0.000 description 1
- 210000004281 subthalamic nucleus Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000602 vitallium Substances 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/337,824 US7502652B2 (en) | 2004-01-22 | 2006-01-23 | Method of routing electrical current to bodily tissues via implanted passive conductors |
| US11/337,824 | 2006-01-23 | ||
| PCT/CA2007/000077 WO2007082382A1 (en) | 2006-01-23 | 2007-01-23 | Method of routing electrical current to bodily tissues via implanted passive conductors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2637851A1 CA2637851A1 (en) | 2007-07-26 |
| CA2637851C true CA2637851C (en) | 2016-01-05 |
Family
ID=38287218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2637851A Active CA2637851C (en) | 2006-01-23 | 2007-01-23 | Method of routing electrical current to bodily tissues via implanted passive conductors |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1981589B1 (enExample) |
| JP (1) | JP5108787B2 (enExample) |
| AU (1) | AU2007207297B2 (enExample) |
| CA (1) | CA2637851C (enExample) |
| WO (1) | WO2007082382A1 (enExample) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2553901C (en) | 2004-01-22 | 2015-01-20 | Rehabtronics Inc. | Method of routing electrical current to bodily tissues via implanted passive conductors |
| US8332029B2 (en) | 2005-06-28 | 2012-12-11 | Bioness Inc. | Implant system and method using implanted passive conductors for routing electrical current |
| US20070073354A1 (en) | 2005-09-26 | 2007-03-29 | Knudson Mark B | Neural blocking therapy |
| US20090204173A1 (en) * | 2007-11-05 | 2009-08-13 | Zi-Ping Fang | Multi-Frequency Neural Treatments and Associated Systems and Methods |
| US8116882B2 (en) | 2008-02-15 | 2012-02-14 | Angeltear Solutions Inc. | Adjustable tissue or nerve cuff and method of use |
| AU2009231601B2 (en) * | 2008-04-04 | 2014-02-27 | Reshape Lifesciences, Inc. | Methods and systems for glucose regulation |
| US20090326602A1 (en) | 2008-06-27 | 2009-12-31 | Arkady Glukhovsky | Treatment of indications using electrical stimulation |
| US8255057B2 (en) | 2009-01-29 | 2012-08-28 | Nevro Corporation | Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions |
| US9327121B2 (en) | 2011-09-08 | 2016-05-03 | Nevro Corporation | Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods |
| EP3228350B1 (en) | 2009-04-22 | 2025-09-24 | Nevro Corporation | Device for selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods |
| EP2756864B1 (en) | 2009-04-22 | 2023-03-15 | Nevro Corporation | Spinal cord modulation systems for inducing paresthetic and anesthetic effects |
| US8498710B2 (en) | 2009-07-28 | 2013-07-30 | Nevro Corporation | Linked area parameter adjustment for spinal cord stimulation and associated systems and methods |
| US9409013B2 (en) | 2009-10-20 | 2016-08-09 | Nyxoah SA | Method for controlling energy delivery as a function of degree of coupling |
| US9950166B2 (en) | 2009-10-20 | 2018-04-24 | Nyxoah SA | Acred implant unit for modulation of nerves |
| US10751537B2 (en) | 2009-10-20 | 2020-08-25 | Nyxoah SA | Arced implant unit for modulation of nerves |
| WO2012075198A2 (en) | 2010-11-30 | 2012-06-07 | Nevro Corporation | Extended pain relief via high frequency spinal cord modulation, and associated systems and methods |
| JP6426085B2 (ja) * | 2012-06-15 | 2018-11-21 | ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎ Ｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ | 損傷のない神経組織伝導ブロック用の治療送達装置および方法 |
| US10195434B2 (en) | 2012-06-15 | 2019-02-05 | Case Western Reserve University | Treatment of pain using electrical nerve conduction block |
| US9694181B2 (en) | 2012-06-15 | 2017-07-04 | Case Western Reserve University | Methods of treatment of a neurological disorder using electrical nerve conduction block |
| US9833614B1 (en) | 2012-06-22 | 2017-12-05 | Nevro Corp. | Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods |
| US9907967B2 (en) | 2012-07-26 | 2018-03-06 | Adi Mashiach | Transcutaneous power conveyance device |
| US11253712B2 (en) | 2012-07-26 | 2022-02-22 | Nyxoah SA | Sleep disordered breathing treatment apparatus |
| EP3705159B1 (en) | 2012-07-26 | 2024-04-10 | Nyxoah SA | Insert tool for selectively powering an implant unit |
| US10052097B2 (en) | 2012-07-26 | 2018-08-21 | Nyxoah SA | Implant unit delivery tool |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| ES2889752T3 (es) * | 2013-01-21 | 2022-01-13 | Cala Health Inc | Dispositivos y métodos para controlar temblores |
| US20150238764A1 (en) | 2013-05-10 | 2015-08-27 | Case Western Reserve University | Systems and methods for preventing noise in an electric waveform for neural stimulation, block, or sensing |
| KR101445148B1 (ko) * | 2013-06-04 | 2014-10-01 | 주식회사 이노테라피 | 생체 이식형 전극 어셈블리 |
| US9895539B1 (en) | 2013-06-10 | 2018-02-20 | Nevro Corp. | Methods and systems for disease treatment using electrical stimulation |
| US9061162B2 (en) | 2013-06-17 | 2015-06-23 | Nyxoah SA | Dynamic modification of modulation throughout a therapy period |
| US10149978B1 (en) | 2013-11-07 | 2018-12-11 | Nevro Corp. | Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods |
| ES2893443T3 (es) * | 2013-11-27 | 2022-02-09 | Ebt Medical Inc | Sistemas para mejorar la activación eléctrica del tejido nervioso |
| US10556107B2 (en) | 2013-11-27 | 2020-02-11 | Ebt Medical, Inc. | Systems, methods and kits for peripheral nerve stimulation |
| US20160263376A1 (en) | 2013-11-27 | 2016-09-15 | The Governing Council Of The University Of Toronto | Systems and methods for improved treatment of overactive bladder |
| US11633593B2 (en) | 2013-11-27 | 2023-04-25 | Ebt Medical, Inc. | Treatment of pelvic floor disorders using targeted lower limb nerve stimulation |
| KR102431161B1 (ko) | 2013-12-22 | 2022-08-10 | 리서치 파운데이션 오브 더 시티 유니버시티 오브 뉴욕 | 트랜스-척추 직류 조절 시스템 |
| EP4241666B1 (en) * | 2013-12-24 | 2024-10-02 | RGB Medical Devices S.A. | Monitoring a neuromuscular blockade status |
| WO2015187712A1 (en) | 2014-06-02 | 2015-12-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| US10688301B2 (en) * | 2014-07-24 | 2020-06-23 | Synapstim Ltd. | Device and methods for delivery of stimulation to a body tissue |
| CN107949421B (zh) | 2015-05-21 | 2021-05-04 | Ebt医药有限责任公司 | 用于治疗泌尿功能障碍的系统和方法 |
| AU2016275135C1 (en) | 2015-06-10 | 2021-09-30 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| US10603482B2 (en) | 2015-09-23 | 2020-03-31 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| AU2016335931B2 (en) | 2015-10-06 | 2019-06-27 | Case Western Reserve University | High-charge capacity electrodes to deliver direct current nerve conduction block |
| US11318310B1 (en) | 2015-10-26 | 2022-05-03 | Nevro Corp. | Neuromodulation for altering autonomic functions, and associated systems and methods |
| US10864373B2 (en) | 2015-12-15 | 2020-12-15 | Case Western Reserve University | Systems for treatment of a neurological disorder using electrical nerve conduction block |
| IL286747B2 (en) | 2016-01-21 | 2024-05-01 | Cala Health Inc | A wearable device for the treatment of symptoms related to the urinary system |
| CN109310865B (zh) | 2016-01-25 | 2022-09-13 | 内弗洛公司 | 电刺激治疗充血性心力衰竭，以及相关联的系统和方法 |
| FR3047669B1 (fr) * | 2016-02-12 | 2021-10-01 | Chu De Rennes Centre Hospitalier Univ De Rennes | Systeme et procede d'application de signaux a des sondes de nerfs vagues pour la prevention de certaines consequences de l'epilepsie |
| US10799701B2 (en) | 2016-03-30 | 2020-10-13 | Nevro Corp. | Systems and methods for identifying and treating patients with high-frequency electrical signals |
| US11446504B1 (en) | 2016-05-27 | 2022-09-20 | Nevro Corp. | High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods |
| US12233265B2 (en) | 2016-08-25 | 2025-02-25 | Cala Health, Inc. | Systems and methods for treating cardiac dysfunction through peripheral nerve stimulation |
| WO2018093765A1 (en) * | 2016-11-15 | 2018-05-24 | Regents Of The University Of California | Methods and apparatuses for improving peripheral nerve function |
| EP3606604A4 (en) | 2017-04-03 | 2020-12-16 | Cala Health, Inc. | PERIPHERAL NEUROMODULATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BLADDER HYPERACTIVITY |
| AU2018249498B2 (en) | 2017-04-03 | 2023-12-14 | Presidio Medical, Inc. | Systems and methods for direct current nerve conduction block |
| WO2018195332A1 (en) * | 2017-04-19 | 2018-10-25 | Indiana University Research And Technology Corporation | Methods and systems for blocking nerve activity propagation in nerve fibers |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| CA3090776A1 (en) | 2018-02-09 | 2019-08-15 | Presidio Medical, Inc. | Systems and methods for cardiac conduction block |
| US11813459B2 (en) | 2018-02-20 | 2023-11-14 | Presidio Medical, Inc. | Methods and systems for nerve conduction block |
| EP3813925B1 (en) | 2018-07-01 | 2025-08-06 | Presidio Medical, Inc. | Systems and methods for nerve conduction block |
| CN113613714A (zh) | 2019-01-17 | 2021-11-05 | 内弗洛公司 | 用于神经疗法筛选和/或参数选择的感觉阈值和/或适应性，以及相关系统和方法 |
| US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
| WO2021007340A1 (en) | 2019-07-08 | 2021-01-14 | Bioness Inc. | Apparatus and methods for providing electric energy to a subject |
| US11065461B2 (en) | 2019-07-08 | 2021-07-20 | Bioness Inc. | Implantable power adapter |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| US12268865B2 (en) | 2019-11-24 | 2025-04-08 | Presidio Medical, Inc. | Current bias as a control mechanism for electrode operation |
| US11730964B2 (en) | 2019-11-24 | 2023-08-22 | Presidio Medical, Inc. | Pulse generation and stimulation engine systems |
| US20240198099A1 (en) * | 2020-07-10 | 2024-06-20 | Duke University | Compositions and methods for treating cancer-associated cachexia |
| WO2022173871A1 (en) | 2021-02-09 | 2022-08-18 | The Regents Of The University Of California | Methods and apparatuses for treating stroke using low-frequency stimulation |
| JP2024513688A (ja) | 2021-03-12 | 2024-03-27 | アンバー セラピューティクス リミテッド | 失禁制御のためのデバイス、システム、および方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3204637A (en) * | 1963-02-07 | 1965-09-07 | Erich J Frank | Stimulating apparatus |
| IL160654A0 (en) * | 2001-08-28 | 2004-07-25 | Medtronic Inc | Implantable medical device for treating cardiac mechanical dysfunction by electrical stimulation |
| US8428717B2 (en) * | 2003-10-14 | 2013-04-23 | Medtronic, Inc. | Method and apparatus for monitoring tissue fluid content for use in an implantable cardiac device |
| US20050165456A1 (en) * | 2003-12-19 | 2005-07-28 | Brian Mann | Digital electrode for cardiac rhythm management |
| CA2553901C (en) * | 2004-01-22 | 2015-01-20 | Rehabtronics Inc. | Method of routing electrical current to bodily tissues via implanted passive conductors |
| US8332029B2 (en) * | 2005-06-28 | 2012-12-11 | Bioness Inc. | Implant system and method using implanted passive conductors for routing electrical current |
-
2007
- 2007-01-23 WO PCT/CA2007/000077 patent/WO2007082382A1/en not_active Ceased
- 2007-01-23 CA CA2637851A patent/CA2637851C/en active Active
- 2007-01-23 JP JP2008551604A patent/JP5108787B2/ja active Active
- 2007-01-23 AU AU2007207297A patent/AU2007207297B2/en active Active
- 2007-01-23 EP EP07701705.1A patent/EP1981589B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007207297B2 (en) | 2011-12-22 |
| JP5108787B2 (ja) | 2012-12-26 |
| AU2007207297A1 (en) | 2007-07-26 |
| EP1981589A4 (en) | 2010-07-07 |
| JP2009529352A (ja) | 2009-08-20 |
| EP1981589A1 (en) | 2008-10-22 |
| EP1981589B1 (en) | 2016-04-13 |
| WO2007082382A1 (en) | 2007-07-26 |
| CA2637851A1 (en) | 2007-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2637851C (en) | Method of routing electrical current to bodily tissues via implanted passive conductors | |
| US9072886B2 (en) | Method of routing electrical current to bodily tissues via implanted passive conductors | |
| US20100016929A1 (en) | Method and system for controlled nerve ablation | |
| US7860570B2 (en) | Implantable microstimulators and methods for unidirectional propagation of action potentials | |
| US7203548B2 (en) | Cavernous nerve stimulation via unidirectional propagation of action potentials | |
| US7292890B2 (en) | Vagus nerve stimulation via unidirectional propagation of action potentials | |
| US9409028B2 (en) | Implantable microstimulators with programmable multielectrode configuration and uses thereof | |
| Prodanov et al. | Functional electric stimulation for sensory and motor functions: progress and problems | |
| WO2004000416A1 (en) | Implantable microstimulators for unidirectional propagation of action potentials | |
| KR20080101931A (ko) | 이식된 수동 전도체를 통해 신체 조직으로 전류를 전달하는방법 | |
| Gan | The stimulus router system: A novel neural prosthesis | |
| Prochazka et al. | Spinal cord and rootlets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |